The global sector for CAR T-cell therapy in treating Non-Hodgkin's lymphoma is undergoing significant growth. This development is fueled by several factors, including rising prevalence of Non-Hodgkin's lymphoma, https://zaynabnvzb793158.mpeblog.com/67121666/worldwide-car-t-cell-therapy-market-for-non-hodgkin-s-lymphoma-growth-trends-and-forecasts